15983230|t|Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.
15983230|a|Impaired insulin secretion is a fundamental defect in type 2 diabetes. The aim of this study was to investigate whether single nucleotide polymorphisms (SNPs) in the genes regulating insulin secretion (SLC2A2 [encoding GLUT2], GCK, TCF1 [encoding HNF-1alpha], HNF4A, GIP, and GLP1R) are associated with the conversion from impaired glucose tolerance (IGT) to type 2 diabetes in participants of the Finnish Diabetes Prevention Study. With the exception of SLC2A2, other genes were not associated with the risk of type 2 diabetes. All four SNPs of SLC2A2 predicted the conversion to diabetes, and rs5393 (AA genotype) increased the risk of type 2 diabetes in the entire study population by threefold (odds ratio 3.04, 95% CI 1.34-6.88, P = 0.008). The risk for type 2 diabetes in the AA genotype carriers was increased in the control group (5.56 [1.78-17.39], P = 0.003) but not in the intervention group. We conclude that the SNPs of SLC2A2 predict the conversion to diabetes in obese subjects with IGT.
15983230	21	27	SLC2A2	GeneOrGeneProduct	6514
15983230	29	34	GLUT2	GeneOrGeneProduct	6514
15983230	81	107	impaired glucose tolerance	DiseaseOrPhenotypicFeature	D018149
15983230	111	126	type 2 diabetes	DiseaseOrPhenotypicFeature	D003924
15983230	140	148	Diabetes	DiseaseOrPhenotypicFeature	D003920
15983230	167	193	Impaired insulin secretion	DiseaseOrPhenotypicFeature	D003920
15983230	221	236	type 2 diabetes	DiseaseOrPhenotypicFeature	D003924
15983230	350	357	insulin	GeneOrGeneProduct	3630
15983230	369	375	SLC2A2	GeneOrGeneProduct	6514
15983230	386	391	GLUT2	GeneOrGeneProduct	6514
15983230	394	397	GCK	GeneOrGeneProduct	2645
15983230	399	403	TCF1	GeneOrGeneProduct	6927
15983230	414	424	HNF-1alpha	GeneOrGeneProduct	6927
15983230	427	432	HNF4A	GeneOrGeneProduct	3172
15983230	434	437	GIP	GeneOrGeneProduct	2695
15983230	443	448	GLP1R	GeneOrGeneProduct	2740
15983230	490	516	impaired glucose tolerance	DiseaseOrPhenotypicFeature	D018149
15983230	518	521	IGT	DiseaseOrPhenotypicFeature	D018149
15983230	526	541	type 2 diabetes	DiseaseOrPhenotypicFeature	D003924
15983230	573	581	Diabetes	DiseaseOrPhenotypicFeature	D003920
15983230	622	628	SLC2A2	GeneOrGeneProduct	6514
15983230	679	694	type 2 diabetes	DiseaseOrPhenotypicFeature	D003924
15983230	713	719	SLC2A2	GeneOrGeneProduct	6514
15983230	748	756	diabetes	DiseaseOrPhenotypicFeature	D003920
15983230	762	768	rs5393	SequenceVariant	rs5393
15983230	805	820	type 2 diabetes	DiseaseOrPhenotypicFeature	D003924
15983230	926	941	type 2 diabetes	DiseaseOrPhenotypicFeature	D003924
15983230	1100	1106	SLC2A2	GeneOrGeneProduct	6514
15983230	1133	1141	diabetes	DiseaseOrPhenotypicFeature	D003920
15983230	1145	1150	obese	DiseaseOrPhenotypicFeature	D009765
15983230	1165	1168	IGT	DiseaseOrPhenotypicFeature	D018149
15983230	Association	rs5393	D018149	Novel
15983230	Association	rs5393	D009765	Novel
15983230	Association	rs5393	D003920	Novel
15983230	Positive_Correlation	rs5393	D003924	Novel
15983230	Association	6514	D018149	Novel
15983230	Association	6514	D009765	Novel
15983230	Association	6514	D003920	Novel
15983230	Association	6514	D003924	Novel
15983230	Association	3630	6514	No
15983230	Association	3630	2740	No
15983230	Association	3630	2695	No
15983230	Association	3630	3172	No
15983230	Association	3630	6927	No
15983230	Association	3630	2645	No